Middle East News Dispatch
SEE OTHER BRANDS

The most trusted news from the Middle East

Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on May 16, 2025

BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer

BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer

PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive …

Erdem Hospital Ushers in a New Chapter of Hope and Healing for Global Patients

Erdem Hospital Ushers in a New Chapter of Hope and Healing for Global Patients

Photo: Erdem Hospital via FL Communications ISTANBUL, May 16, 2025 (GLOBE NEWSWIRE) -- In an era where healthcare transcends borders, Erdem Health Group is emerging as a trusted destination for international patients in pursuit of specialized, high-quality …

Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen

Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen

Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente sichergestellt und die Produktion in Europa gefördert werden sollen. …

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …

Falcon Makes First European Appearance at EBACE 2025

Falcon Makes First European Appearance at EBACE 2025

DUBAI, United Arab Emirates, May 16, 2025 (GLOBE NEWSWIRE) -- With EBACE 2025 just days away, Falcon, part of Alex Group Investment, is getting ready to welcome visitors at its booth during Europe’s leading business aviation event, taking place from May 20 …

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …

Intercom Team Jets into FundedNext for Exclusive AI Collaboration

Intercom Team Jets into FundedNext for Exclusive AI Collaboration

AJMAN, United Arab Emirates, May 16, 2025 (GLOBE NEWSWIRE) -- On May 7–8, FundedNext hosted Intercom’s senior delegation, led by Phil Moore (Head of Sales Engineering) and Ciaran Nolan (Senior Director, EMEA), for a focused two-day collaboration at …

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …

The Economic Times Features Dr. Mohana Rao Patibandla (Dr. Rao) as India’s Leading Minimally Invasive Neurosurgeon

The Economic Times Features Dr. Mohana Rao Patibandla (Dr. Rao) as India’s Leading Minimally Invasive Neurosurgeon

The Economic Times spotlights Dr. Rao’s groundbreaking achievements in neurosurgery, celebrated at the Sardar Patel Unity Summit …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …

Spectral Medical to Present at the 3rd Annual  H.C. Wainwright BioConnect Investor Conference

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …

Falcon Luxe Highlights Bombardier Challenger as Most Requested Aircraft for Private Charter

Falcon Luxe Highlights Bombardier Challenger as Most Requested Aircraft for Private Charter

DUBAI, United Arab Emirates, May 16, 2025 (GLOBE NEWSWIRE) -- Falcon, part of Alex Group Investment, is proud to highlight the Bombardier Challenger as the most requested aircraft in its private jet charter fleet. With two Challenger jets currently in …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service